Intraperitoneal tolmetin prevents postsurgical adhesion formation in rabbits

Area of Science:

• Surgical innovation
• Pharmacology
• Inflammation research

Background:

• Prostaglandin synthesis inhibitors can prevent surgical adhesion formation.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) offer potential for adhesion prevention.
• Optimizing drug delivery is crucial for therapeutic efficacy.

Purpose of the Study:

• To evaluate the efficacy of various delivery systems for tolmetin in preventing intraperitoneal adhesions.
• To compare the potency of different forms of tolmetin (acid vs. sodium salt) in adhesion prevention.
• To investigate the impact of continuous local drug delivery versus systemic injection.

Main Methods:

• Standardized parietal peritoneal injury model in animal subjects.
• Administration of tolmetin via continuous local delivery and single intraperitoneal injection.
• Assessment of adhesion number and severity post-treatment.
• Comparative analysis of tolmetin acid versus sodium salt efficacy.

Main Results:

• Continuous local delivery of small tolmetin amounts significantly reduced adhesion formation and severity.
• Single intraperitoneal injections required higher tolmetin concentrations for comparable effects.
• The acid form of tolmetin demonstrated greater potency than the sodium salt in preventing adhesions.

Conclusions:

• Continuous local delivery of tolmetin is an effective strategy for reducing postsurgical intraperitoneal adhesions.
• Drug formulation and delivery method significantly influence tolmetin's anti-adhesion efficacy.
• Tolmetin acid is more potent than its sodium salt for preventing surgical adhesions.